Viewing StudyNCT00135330



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00135330
Status: COMPLETED
Last Update Posted: 2015-04-07
First Post: 2005-08-24

Brief Title: An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: H8O-US-GWAY
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Eli Lilly and Company INDUSTRY